SlideShare a Scribd company logo
#AIDS2018 | @AIDS_conference | www.aids2018.org
Addressing the first 90: How can HIV
testing more efficiently reach those in
need to promote early diagnosis?
Daniel Simões
HIV in Europe
Portugal
#AIDS2018 | @AIDS_conference | www.aids2018.org
ECDC/EACS Joint Session
Daniel Simões
HIV in Europe Co-chair
Member of the Board @ GAT
Global Public Health PhD fellow @ ISPUP
EATG member
Addressing the first 90: How can HIV testing
more efficiently reach those in need to
promote early diagnosis?
July 23, 2018
#AIDS2018 | @AIDS_conference | www.aids2018.org
Disclosure of interest
• Represented GAT at World Hepatitis Summit,
in 2017 with a travel sponsorship from Abbvie
• Represented GAT at Abbvie’s Global HCV
Advisory Board in 2018 (fee was payed to GAT)
#AIDS2018 | @AIDS_conference | www.aids2018.org
Introductory remarks
• Much has been done; more is needed.
• E/CA are not the world – do not forget the rest of
the world!
• We have to link and learn with each other;
• Strong progress in some parts of the region on
the first 90.
• 90-90-90 is not a magical indicator of success: we
need to understand what it means, what it says
and what it does not say.
#AIDS2018 | @AIDS_conference | www.aids2018.org
Data availability on the continuum of care
2014 (n=40); 2016 (n=44); 2018 (n=43)
Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
11
25
37
35
26
16
4
37
42
41
31
29
9
41
42 42
37
34
0
10
20
30
40
50
No data PLHIV Diagnosed On ART Viral suppression All stages
Nrofcountriesreportingdata
2014 2016 2018
#AIDS2018 | @AIDS_conference | www.aids2018.org
Progress toward achieving the first 90:
Target 1: 90% of all PLHIV who know their status (n=39)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Centre 83%
West 86%
East 76%
Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
*Latest available data reported, ranging from 2014-2017.
Estimated #
PLHIV (1)
% Diagnosed
(2)
Estimated
undiagnosed
number
Missing
Diagnoses per
100.000 (3)
Portugal 38959 92% 3234 31,4
Sweden 7718 90% 772 7,6
Greece 14200 89% 1420 13,1
Romania 14000 88% 1680 8,4
Belgium 11774 83% 2001 17,6
Spain 141000 82% 25380 54,6
Croatia 1680 70% 504 11,8
1: Source: European Centre for Disease Prevention and Control. Thematic report: Continuum of HIV care. Monitoring
implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report.
Stockholm: ECDC; 2017
2: Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
3: Population estimate source: https://en.wikipedia.org/wiki/List_of_European_countries_by_population
#AIDS2018 | @AIDS_conference | www.aids2018.org
Ticking the boxes
• Diagnosis has to be a system of responses. It is about giving
people choices they are comfortable with to get tested.
• A series of boxes have to be ticked – with good monitoring:
– Indicator conditions,
- Pregnant women,
- PICT on geographical hotspots,
- Community located AND community participated VCT
adjusted to your epidemics,
- Self testing/Self sampling,
- Partner notification and contact tracing
– Responses for those out of the box – specific services for
specific needs (mind the overlaps – chemsex and HR)
#AIDS2018 | @AIDS_conference | www.aids2018.org
Are new innovative approaches to HIV testing
included in national HIV testing guidelines? (n=55)
Testing approaches Yes No
No
response
Community-based testing delivered by
trained medical staff
28 12 15
Community-based testing delivered by non-
medical staff (e.g. trained lay people)
14 26 15
Home-sampling kits 4 36 15
Self-testing kits 9 32 14
Source: Dublin Declaration monitoring 2018; validated unpublished data.
Up from 2
in 2017
#AIDS2018 | @AIDS_conference | www.aids2018.org
Implementation of community-based testing by trained
medical staff in Europe and Central Asia, 2018
Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
Implementation of community-based testing by
lay providers in Europe and Central Asia, 2018
#AIDS2018 | @AIDS_conference | www.aids2018.org
Implementation of self-testing in
Europe and Central Asia, 2018
Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
Implementation of self-sampling in Europe
and Central Asia, 2018
#AIDS2018 | @AIDS_conference | www.aids2018.org
Keep in mind
• We need to give people choices (how to test, where to test,
who tests);
• Meaningful participation is crucial!
• Health is our priority but it is not the priority of many people
due to circumstances of life - Social determinants;
• Integration – other diseases (HCV, HBV, STI, TB), other
responses, other stakeholders
• People are not as square as boxes (most people at least) – We
need tailored responses;
• End repression, stigma and discrimination.
Source: Portuguese Community Based Screening Network data, 2016-2017 (unpublished data).Source Portuguese Community Based Screening Network data, 2016-2017 (unpublished data).
#AIDS2018 | @AIDS_conference | www.aids2018.org
An advocacy/protest break
#ChaseTheVirusNotPeople#JustSayNo
#AIDS2018 | @AIDS_conference | www.aids2018.org
Some technicalities
#AIDS2018 | @AIDS_conference | www.aids2018.org
>50%
30 to <40%
<30%
Missing data or did
not report
Luxembourg
Malta
Non-visible countries
Late diagnosis, 2016, EU/EEA
% persons with CD4
<350 cells/mm3 at HIV diagnosis
40 to <50%
Source: ECDC/WHO (2017). HIV/AIDS Surveillance in Europe 2017– 2016 data
• EU/EEA Average: 48%
#AIDS2018 | @AIDS_conference | www.aids2018.org
Comparison of the continuum of care for key
populations, 2018
100%
86%
78% 75%
100%
90%
50%
39%
100%
84%
75% 71%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Living with
HIV
Diagnosed Receiving
ART
Virally
suppressed
Living with
HIV
Diagnosed Receiving
ART
Virally
suppressed
Living with
HIV
Diagnosed Receiving
ART
Virally
suppressed
MSM (n=10) PWID (n=8) Migrants (n=5)
Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
#AIDS2018 | @AIDS_conference | www.aids2018.org
Comparison of the continuum of care for key
populations against national continua, 2018
100%
86%
78% 75%
100%
90%
50%
39%
100%
84%
75% 71%
100%
87%
77%
70%
100%
86%
75%
67%
100%
88%
81%
76%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Living with
HIV
Diagnosed Receiving
ART
Virally
suppressed
Living with
HIV
Diagnosed Receiving
ART
Virally
suppressed
Living with
HIV
Diagnosed Receiving
ART
Virally
suppressed
MSM (n=10) PWID (n=8) Migrants (n=5)
Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
#AIDS2018 | @AIDS_conference | www.aids2018.org
In sum…
• End legal and social repression and stigma;
• Know your epidemics to design your responses;
• Information and literacy are crucial;
• Give people choices of where to go where they feel
good, and that respond to their needs;
• Tick the boxes and remember: one size does not fit all;
• Many things have been tried: look up results and speak
to who did them;
• Involve communities every step of the way!
• However…
#AIDS2018 | @AIDS_conference | www.aids2018.org
Are sufficient funds available for HIV prevention to decrease the
number of new infections in your country? 2018
Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
#AIDS2018 | @AIDS_conference | www.aids2018.org
Closing remarks
(1)2 years to go
Harder, Better, Faster, Stronger
Daft Punk, 2001
#AIDS2018 | @AIDS_conference | www.aids2018.org
Acknowledgments
• ECDC Dublin team, especially Teymur Noori
• Luís Mendão @GATVIH
• The Community Based Screening Network
team in Portugal
• HIV in Europe team
#AIDS2018 | @AIDS_conference | www.aids2018.org
Thank you!

More Related Content

What's hot

What's hot (20)

Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action
 
Testing for Acute HIV and Early Initiation of ART
Testing for Acute HIV and Early Initiation of ARTTesting for Acute HIV and Early Initiation of ART
Testing for Acute HIV and Early Initiation of ART
 
Antibiotic Guardian London Workshop
Antibiotic Guardian London WorkshopAntibiotic Guardian London Workshop
Antibiotic Guardian London Workshop
 
Gam 2017 guidelines
Gam 2017 guidelinesGam 2017 guidelines
Gam 2017 guidelines
 
Global AIDS Response Progress Reporting
Global AIDS Response Progress ReportingGlobal AIDS Response Progress Reporting
Global AIDS Response Progress Reporting
 
New approaches and new technologies to improve access to HIV testing
New approaches and new technologies to improve access to HIV testingNew approaches and new technologies to improve access to HIV testing
New approaches and new technologies to improve access to HIV testing
 
Africa CDC, FIND partner to build capacity for COVID-19 rapid diagnostic test...
Africa CDC, FIND partner to build capacity for COVID-19 rapid diagnostic test...Africa CDC, FIND partner to build capacity for COVID-19 rapid diagnostic test...
Africa CDC, FIND partner to build capacity for COVID-19 rapid diagnostic test...
 
HEVnet: Sharing sequences & metadata of hepatitis E virus
HEVnet: Sharing sequences & metadata of hepatitis E virus HEVnet: Sharing sequences & metadata of hepatitis E virus
HEVnet: Sharing sequences & metadata of hepatitis E virus
 
Healthy animals for healthy lives in low- and middle-income countries
Healthy animals for healthy lives in low- and middle-income countriesHealthy animals for healthy lives in low- and middle-income countries
Healthy animals for healthy lives in low- and middle-income countries
 
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
 
Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019
Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019
Dr Jayne Ellis @ MRF's Meningitis and Septicaemia 2019
 
THE GLOBAL AIDS RESPONSE PROGRESS REPORT | 2016 FAQ
THE GLOBAL AIDS RESPONSE PROGRESS REPORT | 2016 FAQTHE GLOBAL AIDS RESPONSE PROGRESS REPORT | 2016 FAQ
THE GLOBAL AIDS RESPONSE PROGRESS REPORT | 2016 FAQ
 
Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018
 
www.medicotesting.com , AIDS ppt
www.medicotesting.com , AIDS pptwww.medicotesting.com , AIDS ppt
www.medicotesting.com , AIDS ppt
 
GLOBAL AIDS RESPONSE PROGRESS REPORTING 2016
GLOBAL AIDS RESPONSE PROGRESS REPORTING 2016GLOBAL AIDS RESPONSE PROGRESS REPORTING 2016
GLOBAL AIDS RESPONSE PROGRESS REPORTING 2016
 
Potential impact of conflict on Haemoglobinopathies - Carsten W. Lederer
Potential impact of conflict on Haemoglobinopathies - Carsten W. LedererPotential impact of conflict on Haemoglobinopathies - Carsten W. Lederer
Potential impact of conflict on Haemoglobinopathies - Carsten W. Lederer
 
Prof Martin Antonio @ MRF's Meningitis and Septicaemia 2019
Prof Martin Antonio @ MRF's Meningitis and Septicaemia 2019 Prof Martin Antonio @ MRF's Meningitis and Septicaemia 2019
Prof Martin Antonio @ MRF's Meningitis and Septicaemia 2019
 
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
 
Claire Wright @ MRF's Meningitis and Septicaemia 2019
Claire Wright @ MRF's Meningitis and Septicaemia 2019  Claire Wright @ MRF's Meningitis and Septicaemia 2019
Claire Wright @ MRF's Meningitis and Septicaemia 2019
 
The HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersThe HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura Waters
 

Similar to Addressing the first 90: How can HIV testing more efficiently reach those in need to promote early diagnosis?

current hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overviewcurrent hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overview
ikramdr01
 
Fast track, incestment spproach and transition funding to end aids epidemic b...
Fast track, incestment spproach and transition funding to end aids epidemic b...Fast track, incestment spproach and transition funding to end aids epidemic b...
Fast track, incestment spproach and transition funding to end aids epidemic b...
PinHealth
 
APCRSHR10 Virtual plenary presentation of Eamonn Murphy, Regional Director of...
APCRSHR10 Virtual plenary presentation of Eamonn Murphy, Regional Director of...APCRSHR10 Virtual plenary presentation of Eamonn Murphy, Regional Director of...
APCRSHR10 Virtual plenary presentation of Eamonn Murphy, Regional Director of...
CNS www.citizen-news.org
 

Similar to Addressing the first 90: How can HIV testing more efficiently reach those in need to promote early diagnosis? (20)

Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe
 
philippines-slides-aug-2022.pptx
philippines-slides-aug-2022.pptxphilippines-slides-aug-2022.pptx
philippines-slides-aug-2022.pptx
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 
Addressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in careAddressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in care
 
2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf
 
Fast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in EuropeFast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in Europe
 
Presentation –Action plan for the health sector response to HIV
Presentation –Action plan for the health sector response to HIV Presentation –Action plan for the health sector response to HIV
Presentation –Action plan for the health sector response to HIV
 
current hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overviewcurrent hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overview
 
PrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptx
PrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptxPrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptx
PrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptx
 
Fast track, incestment spproach and transition funding to end aids epidemic b...
Fast track, incestment spproach and transition funding to end aids epidemic b...Fast track, incestment spproach and transition funding to end aids epidemic b...
Fast track, incestment spproach and transition funding to end aids epidemic b...
 
National AIDS control program
National AIDS control programNational AIDS control program
National AIDS control program
 
APCRSHR10 Virtual plenary presentation of Eamonn Murphy, Regional Director of...
APCRSHR10 Virtual plenary presentation of Eamonn Murphy, Regional Director of...APCRSHR10 Virtual plenary presentation of Eamonn Murphy, Regional Director of...
APCRSHR10 Virtual plenary presentation of Eamonn Murphy, Regional Director of...
 
Naco
NacoNaco
Naco
 
NACO.pptx
NACO.pptxNACO.pptx
NACO.pptx
 
Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...
 

More from European Centre for Disease Prevention and Control

More from European Centre for Disease Prevention and Control (20)

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 
Latest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDCLatest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDC
 
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
 
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
 
Hepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 dataHepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 data
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptx
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
The History of Diagnostic Medical imaging
The History of Diagnostic Medical imagingThe History of Diagnostic Medical imaging
The History of Diagnostic Medical imaging
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 

Addressing the first 90: How can HIV testing more efficiently reach those in need to promote early diagnosis?

  • 1. #AIDS2018 | @AIDS_conference | www.aids2018.org Addressing the first 90: How can HIV testing more efficiently reach those in need to promote early diagnosis? Daniel Simões HIV in Europe Portugal
  • 2. #AIDS2018 | @AIDS_conference | www.aids2018.org ECDC/EACS Joint Session Daniel Simões HIV in Europe Co-chair Member of the Board @ GAT Global Public Health PhD fellow @ ISPUP EATG member Addressing the first 90: How can HIV testing more efficiently reach those in need to promote early diagnosis? July 23, 2018
  • 3. #AIDS2018 | @AIDS_conference | www.aids2018.org Disclosure of interest • Represented GAT at World Hepatitis Summit, in 2017 with a travel sponsorship from Abbvie • Represented GAT at Abbvie’s Global HCV Advisory Board in 2018 (fee was payed to GAT)
  • 4. #AIDS2018 | @AIDS_conference | www.aids2018.org Introductory remarks • Much has been done; more is needed. • E/CA are not the world – do not forget the rest of the world! • We have to link and learn with each other; • Strong progress in some parts of the region on the first 90. • 90-90-90 is not a magical indicator of success: we need to understand what it means, what it says and what it does not say.
  • 5. #AIDS2018 | @AIDS_conference | www.aids2018.org Data availability on the continuum of care 2014 (n=40); 2016 (n=44); 2018 (n=43) Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data. 11 25 37 35 26 16 4 37 42 41 31 29 9 41 42 42 37 34 0 10 20 30 40 50 No data PLHIV Diagnosed On ART Viral suppression All stages Nrofcountriesreportingdata 2014 2016 2018
  • 6. #AIDS2018 | @AIDS_conference | www.aids2018.org Progress toward achieving the first 90: Target 1: 90% of all PLHIV who know their status (n=39) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Centre 83% West 86% East 76% Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data. *Latest available data reported, ranging from 2014-2017. Estimated # PLHIV (1) % Diagnosed (2) Estimated undiagnosed number Missing Diagnoses per 100.000 (3) Portugal 38959 92% 3234 31,4 Sweden 7718 90% 772 7,6 Greece 14200 89% 1420 13,1 Romania 14000 88% 1680 8,4 Belgium 11774 83% 2001 17,6 Spain 141000 82% 25380 54,6 Croatia 1680 70% 504 11,8 1: Source: European Centre for Disease Prevention and Control. Thematic report: Continuum of HIV care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017 2: Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data. 3: Population estimate source: https://en.wikipedia.org/wiki/List_of_European_countries_by_population
  • 7. #AIDS2018 | @AIDS_conference | www.aids2018.org Ticking the boxes • Diagnosis has to be a system of responses. It is about giving people choices they are comfortable with to get tested. • A series of boxes have to be ticked – with good monitoring: – Indicator conditions, - Pregnant women, - PICT on geographical hotspots, - Community located AND community participated VCT adjusted to your epidemics, - Self testing/Self sampling, - Partner notification and contact tracing – Responses for those out of the box – specific services for specific needs (mind the overlaps – chemsex and HR)
  • 8. #AIDS2018 | @AIDS_conference | www.aids2018.org Are new innovative approaches to HIV testing included in national HIV testing guidelines? (n=55) Testing approaches Yes No No response Community-based testing delivered by trained medical staff 28 12 15 Community-based testing delivered by non- medical staff (e.g. trained lay people) 14 26 15 Home-sampling kits 4 36 15 Self-testing kits 9 32 14 Source: Dublin Declaration monitoring 2018; validated unpublished data. Up from 2 in 2017
  • 9. #AIDS2018 | @AIDS_conference | www.aids2018.org Implementation of community-based testing by trained medical staff in Europe and Central Asia, 2018 Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data. Implementation of community-based testing by lay providers in Europe and Central Asia, 2018
  • 10. #AIDS2018 | @AIDS_conference | www.aids2018.org Implementation of self-testing in Europe and Central Asia, 2018 Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data. Implementation of self-sampling in Europe and Central Asia, 2018
  • 11. #AIDS2018 | @AIDS_conference | www.aids2018.org Keep in mind • We need to give people choices (how to test, where to test, who tests); • Meaningful participation is crucial! • Health is our priority but it is not the priority of many people due to circumstances of life - Social determinants; • Integration – other diseases (HCV, HBV, STI, TB), other responses, other stakeholders • People are not as square as boxes (most people at least) – We need tailored responses; • End repression, stigma and discrimination. Source: Portuguese Community Based Screening Network data, 2016-2017 (unpublished data).Source Portuguese Community Based Screening Network data, 2016-2017 (unpublished data).
  • 12. #AIDS2018 | @AIDS_conference | www.aids2018.org An advocacy/protest break #ChaseTheVirusNotPeople#JustSayNo
  • 13. #AIDS2018 | @AIDS_conference | www.aids2018.org Some technicalities
  • 14. #AIDS2018 | @AIDS_conference | www.aids2018.org >50% 30 to <40% <30% Missing data or did not report Luxembourg Malta Non-visible countries Late diagnosis, 2016, EU/EEA % persons with CD4 <350 cells/mm3 at HIV diagnosis 40 to <50% Source: ECDC/WHO (2017). HIV/AIDS Surveillance in Europe 2017– 2016 data • EU/EEA Average: 48%
  • 15. #AIDS2018 | @AIDS_conference | www.aids2018.org Comparison of the continuum of care for key populations, 2018 100% 86% 78% 75% 100% 90% 50% 39% 100% 84% 75% 71% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Living with HIV Diagnosed Receiving ART Virally suppressed Living with HIV Diagnosed Receiving ART Virally suppressed Living with HIV Diagnosed Receiving ART Virally suppressed MSM (n=10) PWID (n=8) Migrants (n=5) Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
  • 16. #AIDS2018 | @AIDS_conference | www.aids2018.org Comparison of the continuum of care for key populations against national continua, 2018 100% 86% 78% 75% 100% 90% 50% 39% 100% 84% 75% 71% 100% 87% 77% 70% 100% 86% 75% 67% 100% 88% 81% 76% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Living with HIV Diagnosed Receiving ART Virally suppressed Living with HIV Diagnosed Receiving ART Virally suppressed Living with HIV Diagnosed Receiving ART Virally suppressed MSM (n=10) PWID (n=8) Migrants (n=5) Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
  • 17. #AIDS2018 | @AIDS_conference | www.aids2018.org In sum… • End legal and social repression and stigma; • Know your epidemics to design your responses; • Information and literacy are crucial; • Give people choices of where to go where they feel good, and that respond to their needs; • Tick the boxes and remember: one size does not fit all; • Many things have been tried: look up results and speak to who did them; • Involve communities every step of the way! • However…
  • 18. #AIDS2018 | @AIDS_conference | www.aids2018.org Are sufficient funds available for HIV prevention to decrease the number of new infections in your country? 2018 Source: ECDC. Dublin Declaration monitoring 2018; validated unpublished data.
  • 19. #AIDS2018 | @AIDS_conference | www.aids2018.org Closing remarks (1)2 years to go Harder, Better, Faster, Stronger Daft Punk, 2001
  • 20. #AIDS2018 | @AIDS_conference | www.aids2018.org Acknowledgments • ECDC Dublin team, especially Teymur Noori • Luís Mendão @GATVIH • The Community Based Screening Network team in Portugal • HIV in Europe team
  • 21. #AIDS2018 | @AIDS_conference | www.aids2018.org Thank you!